PTIE Pain Therapeutics Inc.

1.03
-0.05  -5%
Previous Close 1.08
Open 1.08
Price To Book 0.89
Market Cap 17735879
Shares 17,219,300
Volume 198,047
Short Ratio
Av. Daily Volume 2,595,785

SEC filingsSee all SEC filings

  1. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 181226095
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 181147345
  3. 8-K - Current report 181144280
  4. 8-K - Current report 181118489
  5. 8-K - Current report 181108544

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued September 26, 2016. NDA refiled but additional CRL issued August 6, 2018. Noted November 12, 2018 that it will meet with the FDA January 31, 2019 to discuss further.
Remoxy
Chronic pain
Phase 2 trial initiation announced December 6, 2018.
PTI-125
Alzheimer’s disease